Evidence map›Paper›PMID 32029454›Full record

ReviewGenes & development2020

The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions.

Anthony R Fehr, Sasha A Singh, Catherine M Kerr, Shin Mukai, Hideyuki Higashi, Masanori Aikawa

Open access · diamondAbstract readReview
In one paragraph

Review in Genes & development, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 159 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
159citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

159 citing papers in PubMed, 1 synthesis or guideline pooled it, 226 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Fully protected pyrophosphatesChemical science · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. NADFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

99 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Anthony R FehrDepartment of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA.
Sasha A SinghCenter for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Catherine M KerrDepartment of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA.
Shin MukaiCenter for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Hideyuki HigashiCenter for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Masanori AikawaCenter for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Brigham and Women's Hospital · USUniversity of Kansas · US

Funding

Synthetic Chemical Biology CoreP20GM113117 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI JOHNSON, DAVID K · 2016 to 2025
$23.9M
PARP9 and PARP14 in atherosclerosisR01HL126901 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI AIKAWA, MASANORI · 2016 to 2019
$2.4M
Investigating How ADP-ribosylation Impacts Innate Immunity During Coronavirus InfectionK22AI134993 · NIAID · UNIVERSITY OF KANSAS LAWRENCE · PI FEHR, ANTHONY R · 2019 to 2020
$270k
NHLBI NIH HHS R01 HL126901NIAID NIH HHS K22 AI134993NIGMS NIH HHS P20 GM113117
6 · The paper itself

Abstract

Poly-adenosine diphosphate-ribose polymerases (PARPs) promote ADP-ribosylation, a highly conserved, fundamental posttranslational modification (PTM). PARP catalytic domains transfer the ADP-ribose moiety from NAD

Indexed as

InflammationADP-RibosylationHost-Pathogen InteractionsHumansMacrophagesPoly(ADP-ribose) PolymerasesProteomicsResearchSystems BiologyVirus DiseasesPoly(ADP-ribose) PolymerasesADP-ribosylationatherosclerosishost–pathogen interactionsimmunityinflammationmacrophagePARPvascular disease

Identifiers

PMID32029454
PMCPMC7050484
OpenAlexW3005531462

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.